XML 38 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Jan. 31, 2013
Jan. 31, 2012
Cash Flows From Operating Activities:    
Net income $ 62,127 $ 64,870
Adjustments to reconcile net income to net cash used for operating activities:    
Depreciation and amortization 5,736 6,314
Amortization of deferred sales commissions 4,801 5,827
Stock-based compensation 14,023 16,342
Deferred income taxes (192) (3,821)
Net gains on investments and derivatives (4,751) (6,430)
Equity in net income of affiliates, net of amortization (3,859) (2,417)
Dividends received from affiliates 3,092 10,225
Consolidated CLO entity operating activities:    
Net losses (gains) on bank loans, other investments and note obligations 3,052 (4,736)
Amortization of investments (201) (256)
Net (decrease) increase in other assets and liabilities, including cash (11,438) 2,771
Changes in operating assets and liabilities:    
Investment advisory fees and other receivables (8,941) 3,785
Investments in trading securities (40,908) (70,263)
Deferred sales commissions (4,207) (2,322)
Other assets (7,167) 3,964
Accrued compensation (86,898) (87,633)
Accounts payable and accrued expenses (2,251) 9,647
Other liabilities 5,776 45,918
Net cash used for operating activities (72,206) (8,215)
Cash Flows From Investing Activities:    
Additions to equipment and leasehold improvements (1,002) (1,486)
Net cash paid in acquisition (81,269) 0
Proceeds from sales of investments 44,102 14,542
Purchase of investments (344) (6,126)
Consolidated CLO entity investing activities:    
Proceeds from sales and maturities of bank loans and other investments 74,972 32,512
Purchase of bank loans and other investments (24,327) (35,221)
Net cash provided by investing activities 12,132 4,221
Cash Flows From Financing Activities:    
Purchase of additional non-controlling interest (43,507)  
Proceeds from issuance of subsidiary equity 1,092  
Proceeds from issuance of Non-Voting Common Stock 59,673 6,037
Repurchase of Voting Common Stock (73)  
Repurchase of Non-Voting Common Stock (13,282) (34,800)
Principal repayments on notes receivable from stock option exercises 931 460
Excess tax benefit of stock option exercises 8,253 225
Dividends paid (166,979) (21,967)
Net subscriptions received from (redemptions/distributions paid to) non-controlling interest holders 8,924 18,534
Consolidated CLO Entity Financing Activities:    
Principal repayments of senior notes (38,607)  
Net cash used for financing activities (183,575) (31,511)
Effect of currency rate changes on cash and cash equivalents (144) (38)
Net decrease in cash and cash equivalents (243,793) (35,543)
Cash and cash equivalents, beginning of period 462,076 510,913
Cash and cash equivalents, end of period 218,283 475,370
Supplemental Cash Flow Information:    
Cash paid for interest 113 36
Cash paid for interest by consolidated CLO entity 4,600 722
Cash paid for income taxes, net of refunds 3,812 9,683
Supplemental Disclosure of Non-Cash Information:    
Increase in equipment and leasehold improvements due to non-cash additions 565 142
Exercise of stock options through issuance of notes receivable 4,464 137
Deconsolidations of Sponsored Investment Funds:    
Decrease in investments (10,533) (16,470)
Decrease in non-controlling interests $ (10,155) $ (16,564)